Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	534-535
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	54
Issue number	4
DOIs	https://doi.org/10.1111/apt.16505
Publication status	Published - 1 Aug 2021

Access to Document

@article{d32f7e0839044c19af3e4d4d5954ca09,

title = "Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply",

author = "V.B.C. Biemans and T. Straatmijer and F. Hoentjen and M.J. Pierik",

year = "2021",

month = aug,

day = "1",

doi = "10.1111/apt.16505",

language = "English",

volume = "54",

pages = "534--535",

journal = "Alimentary Pharmacology \& Therapeutics",

issn = "0269-2813",

publisher = "John Wiley \& Sons Inc.",

number = "4",

}

Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply. / Biemans, V.B.C.; Straatmijer, T.; Hoentjen, F. et al.
In: Alimentary Pharmacology & Therapeutics, Vol. 54, No. 4, 01.08.2021, p. 534-535.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply

AU - Biemans, V.B.C.

AU - Straatmijer, T.

AU - Hoentjen, F.

AU - Pierik, M.J.

PY - 2021/8/1

Y1 - 2021/8/1

U2 - 10.1111/apt.16505

DO - 10.1111/apt.16505

M3 - Comment/Letter to the editor

C2 - 34331810

SN - 0269-2813

VL - 54

SP - 534

EP - 535

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 4

ER -